Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8308535rdf:typepubmed:Citationlld:pubmed
pubmed-article:8308535lifeskim:mentionsumls-concept:C0001818lld:lifeskim
pubmed-article:8308535lifeskim:mentionsumls-concept:C0003469lld:lifeskim
pubmed-article:8308535lifeskim:mentionsumls-concept:C0030318lld:lifeskim
pubmed-article:8308535lifeskim:mentionsumls-concept:C1511726lld:lifeskim
pubmed-article:8308535lifeskim:mentionsumls-concept:C0236800lld:lifeskim
pubmed-article:8308535lifeskim:mentionsumls-concept:C2603343lld:lifeskim
pubmed-article:8308535pubmed:issue2lld:pubmed
pubmed-article:8308535pubmed:dateCreated1994-3-15lld:pubmed
pubmed-article:8308535pubmed:abstractTextIn a cross-sectional investigation of the properties of DSM-III-R panic disorder (PD), panic disorder with agoraphobia (PDA), and agoraphobia without history of panic disorder (AWOPD), we analyzed demographic, descriptive, comorbidity, treatment, and course data for 562 subjects with PD, PDA, or AWOPD in a multicenter anxiety-disorders study. In general, AWOPD subjects had the worst functioning and PD subjects the best, as measured by length of intake episodes, education attained, likelihood of receiving financial assistance, depressive comorbidity, and likelihood of having experienced 8 weeks symptom-free. Panic disorder with agoraphobia was the most common disorder and emerged as a condition intermediate in severity between the other two. Treatments received varied little by diagnosis. Most subjects received medication, usually benzodiazepines. Psychodynamic psychotherapy was the most frequently received psychosocial treatment; cognitive and behavioral approaches were less common. Subjects classified with AWOPD were the most likely to have received exposure therapies.lld:pubmed
pubmed-article:8308535pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8308535pubmed:languageenglld:pubmed
pubmed-article:8308535pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8308535pubmed:citationSubsetAIMlld:pubmed
pubmed-article:8308535pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8308535pubmed:statusMEDLINElld:pubmed
pubmed-article:8308535pubmed:monthFeblld:pubmed
pubmed-article:8308535pubmed:issn0022-3018lld:pubmed
pubmed-article:8308535pubmed:authorpubmed-author:RogersM PMPlld:pubmed
pubmed-article:8308535pubmed:authorpubmed-author:CuneoPPlld:pubmed
pubmed-article:8308535pubmed:authorpubmed-author:GoismanR MRMlld:pubmed
pubmed-article:8308535pubmed:authorpubmed-author:PetersonL GLGlld:pubmed
pubmed-article:8308535pubmed:authorpubmed-author:WarshawM GMGlld:pubmed
pubmed-article:8308535pubmed:authorpubmed-author:HuntM FMFlld:pubmed
pubmed-article:8308535pubmed:authorpubmed-author:GollanJ KJKlld:pubmed
pubmed-article:8308535pubmed:authorpubmed-author:Tomlin-Albane...lld:pubmed
pubmed-article:8308535pubmed:authorpubmed-author:KazimAAlld:pubmed
pubmed-article:8308535pubmed:authorpubmed-author:Epstein-KayeT...lld:pubmed
pubmed-article:8308535pubmed:issnTypePrintlld:pubmed
pubmed-article:8308535pubmed:volume182lld:pubmed
pubmed-article:8308535pubmed:ownerNLMlld:pubmed
pubmed-article:8308535pubmed:authorsCompleteNlld:pubmed
pubmed-article:8308535pubmed:pagination72-9lld:pubmed
pubmed-article:8308535pubmed:dateRevised2011-2-3lld:pubmed
pubmed-article:8308535pubmed:meshHeadingpubmed-meshheading:8308535-...lld:pubmed
pubmed-article:8308535pubmed:meshHeadingpubmed-meshheading:8308535-...lld:pubmed
pubmed-article:8308535pubmed:meshHeadingpubmed-meshheading:8308535-...lld:pubmed
pubmed-article:8308535pubmed:meshHeadingpubmed-meshheading:8308535-...lld:pubmed
pubmed-article:8308535pubmed:meshHeadingpubmed-meshheading:8308535-...lld:pubmed
pubmed-article:8308535pubmed:meshHeadingpubmed-meshheading:8308535-...lld:pubmed
pubmed-article:8308535pubmed:meshHeadingpubmed-meshheading:8308535-...lld:pubmed
pubmed-article:8308535pubmed:meshHeadingpubmed-meshheading:8308535-...lld:pubmed
pubmed-article:8308535pubmed:meshHeadingpubmed-meshheading:8308535-...lld:pubmed
pubmed-article:8308535pubmed:meshHeadingpubmed-meshheading:8308535-...lld:pubmed
pubmed-article:8308535pubmed:meshHeadingpubmed-meshheading:8308535-...lld:pubmed
pubmed-article:8308535pubmed:meshHeadingpubmed-meshheading:8308535-...lld:pubmed
pubmed-article:8308535pubmed:meshHeadingpubmed-meshheading:8308535-...lld:pubmed
pubmed-article:8308535pubmed:meshHeadingpubmed-meshheading:8308535-...lld:pubmed
pubmed-article:8308535pubmed:meshHeadingpubmed-meshheading:8308535-...lld:pubmed
pubmed-article:8308535pubmed:meshHeadingpubmed-meshheading:8308535-...lld:pubmed
pubmed-article:8308535pubmed:meshHeadingpubmed-meshheading:8308535-...lld:pubmed
pubmed-article:8308535pubmed:meshHeadingpubmed-meshheading:8308535-...lld:pubmed
pubmed-article:8308535pubmed:year1994lld:pubmed
pubmed-article:8308535pubmed:articleTitlePanic, agoraphobia, and panic disorder with agoraphobia. Data from a multicenter anxiety disorders study.lld:pubmed
pubmed-article:8308535pubmed:affiliationMassachusetts Mental Health Center, Boston 02115.lld:pubmed
pubmed-article:8308535pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8308535pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:8308535pubmed:publicationTypeMulticenter Studylld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8308535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8308535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8308535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8308535lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8308535lld:pubmed